A Agilent Technologies | Target Raised by | Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $146.58 -1.3% | $135.00 ➝ $145.00 | In-Line ➝ In-Line | |
AA Alcoa | Upgraded by | Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $39.19 +1.6% | $43.00 ➝ $52.00 | Neutral ➝ Buy | |
AAPL Apple | Reiterated by | Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $226.21 -2.9% | $250.00 | Buy | |
AAPL Apple | Reiterated by | Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $226.21 -2.9% | $186.00 ➝ $186.00 | Underweight ➝ Underweight | |
ABT Abbott Laboratories | Target Raised by | Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $113.58 -0.4% | $120.00 ➝ $124.00 | Outperform ➝ Outperform | |
ACHC Acadia Healthcare | Reiterated by | Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $62.41 -1.6% | $90.00 ➝ $90.00 | Neutral ➝ Neutral | |
[Urgent!] Web3 Could Send One Crypto Soaring (Ad) Venture Capital corporations and blockchain funds are pouring money into Web3 gaming.
And there's one little-known crypto coin that's poised for RAPID growth as we see Web3 expand over the next few years. Click here to review my research and unique strategy to score potential profits from this under-the- |
ACMR ACM Research | Reiterated by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $19.03 -6.3% | $25.00 ➝ $25.00 | Buy ➝ Buy | |
ADC Agree Realty | Reiterated by | Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $75.26 -0.1% | $77.00 ➝ $80.00 | Overweight ➝ Overweight | |
AEON AEON Biopharma | Reiterated by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $1.02 -2.9% | $5.00 ➝ $5.00 | Buy ➝ Buy | |
AEYE AudioEye | Target Raised by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $22.83 -0.1% | $23.00 ➝ $28.00 | Buy ➝ Buy | |
ANEB Anebulo Pharmaceuticals | Reiterated by | Benchmark Subscribe to MarketBeat All Access for the recommendation accuracy rating | R. Wasserman Subscribe to MarketBeat All Access for the recommendation accuracy rating | $1.98 +2.6% | $8.00 ➝ $8.00 | Speculative Buy ➝ Speculative Buy | |
ANET Arista Networks | Target Raised by | Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $381.72 -0.5% | $400.00 ➝ $425.00 | Outperform ➝ Outperform | |
ANVS Annovis Bio | Reiterated by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $7.93 -1.6% | $30.00 ➝ $30.00 | Buy ➝ Buy | |
APA APA | Target Lowered by | Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $25.66 +4.9% | $49.00 ➝ $47.00 | Overweight ➝ Overweight | |
APTV Aptiv | Downgraded by | Fox Advisors Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $70.52 -2.1% | | Overweight ➝ Equal Weight | |
AR Antero Resources | Downgraded by | Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating | R. Read Subscribe to MarketBeat All Access for the recommendation accuracy rating | $28.66 +0.0% | $34.00 ➝ $25.00 | Overweight ➝ Underweight | |
ARCT Arcturus Therapeutics | Reiterated by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $25.25 +8.8% | $63.00 ➝ $63.00 | Buy ➝ Buy | |
AZTA Azenta | Target Lowered by | Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $47.50 -1.9% | $53.00 ➝ $50.00 | In-Line ➝ In-Line | |
BA Boeing | Target Lowered by | Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating | M. Akers Subscribe to MarketBeat All Access for the recommendation accuracy rating | $154.24 +1.4% | $119.00 ➝ $110.00 | Underweight ➝ Underweight | |
BA Boeing | Target Lowered by | TD Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $154.24 +1.4% | $230.00 ➝ $200.00 | Buy ➝ Buy | |
BAH Booz Allen Hamilton | Target Raised by | Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating | M. Akers Subscribe to MarketBeat All Access for the recommendation accuracy rating | $163.41 +0.4% | $165.00 ➝ $185.00 | Overweight ➝ Overweight | |
BANC Banc of California | Target Raised by | Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $14.06 -4.6% | $15.00 ➝ $16.00 | Equal Weight ➝ Equal Weight | |
BAX Baxter International | Target Raised by | Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $36.91 -2.8% | $38.00 ➝ $40.00 | Neutral ➝ Neutral | |
BDX Becton, Dickinson and Company | Target Raised by | Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $241.66 +0.2% | $286.00 ➝ $290.00 | Outperform ➝ Outperform | |
BDX Becton, Dickinson and Company | Upgraded by | Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating | J. Wuensch Subscribe to MarketBeat All Access for the recommendation accuracy rating | $241.66 +0.2% | $255.00 ➝ $275.00 | Neutral ➝ Buy | |
BELFB Bel Fuse | Target Raised by | Northland Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $80.50 +2.5% | $80.00 ➝ $95.00 | Outperform ➝ Outperform | |
BIO Bio-Rad Laboratories | Upgraded by | Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating | P. Donnelly Subscribe to MarketBeat All Access for the recommendation accuracy rating | $337.89 +1.0% | $350.00 ➝ $400.00 | Neutral ➝ Buy | |
BKD Brookdale Senior Living | Reiterated by | Macquarie Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $6.60 -2.8% | $8.00 ➝ $8.00 | Outperform ➝ Outperform | |
BKU BankUnited | Target Raised by | Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $35.24 -3.3% | $35.00 ➝ $38.00 | Equal Weight ➝ Equal Weight | |
BLCO Bausch + Lomb | Target Raised by | Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $19.14 -0.8% | $17.00 ➝ $19.00 | In-Line ➝ In-Line | |
BLK BlackRock | Target Raised by | JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $934.10 -1.6% | $774.00 ➝ $864.00 | Neutral ➝ Neutral | |
BOKF BOK Financial | Target Raised by | Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $101.23 -3.2% | $100.00 ➝ $102.00 | Equal Weight ➝ Equal Weight | |
BOOT Boot Barn | Target Raised by | Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $166.60 -0.4% | $140.00 ➝ $167.00 | Neutral ➝ Neutral | |
BPOP Popular | Downgraded by | Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating | T. Braziler Subscribe to MarketBeat All Access for the recommendation accuracy rating | $95.40 -4.9% | $115.00 ➝ $105.00 | Overweight ➝ Equal Weight | |
BSX Boston Scientific | Target Raised by | Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $84.14 +0.4% | $82.00 ➝ $90.00 | Outperform ➝ Outperform | |
BTSG BrightSpring Health Services | Target Raised by | Guggenheim Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $14.78 +0.7% | $15.00 ➝ $18.00 | Buy ➝ Buy | |
BUD Anheuser-Busch InBev SA/NV | Upgraded by | Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating | S. Hales Subscribe to MarketBeat All Access for the recommendation accuracy rating | $66.55 +0.4% | | Neutral ➝ Buy | |
BWA BorgWarner | Target Lowered by | The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $35.49 -2.2% | $38.00 ➝ $36.00 | Neutral ➝ Neutral | |
CACI CACI International | Target Raised by | Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $505.23 +0.1% | $525.00 ➝ $577.00 | Overweight ➝ Overweight | |
CATX Perspective Therapeutics | Initiated by | Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $12.59 -5.7% | $25.00 | Outperform | |
[Urgent!] Web3 Could Send One Crypto Soaring (Ad) Venture Capital corporations and blockchain funds are pouring money into Web3 gaming.
And there's one little-known crypto coin that's poised for RAPID growth as we see Web3 expand over the next few years. Click here to review my research and unique strategy to score potential profits from this under-the- |
CCL Carnival Co. & | Target Raised by | Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $18.02 -2.5% | $15.00 ➝ $16.50 | Underweight ➝ Underweight | |
CCL Carnival Co. & | Target Raised by | Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $18.02 -2.5% | $25.00 ➝ $26.00 | Outperform ➝ Outperform | |
CCL Carnival Co. & | Target Raised by | Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $18.02 -2.5% | $25.00 ➝ $26.00 | Overweight ➝ Overweight | |
CDW CDW | Downgraded by | Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating | A. Merchant Subscribe to MarketBeat All Access for the recommendation accuracy rating | $217.81 -3.8% | $250.00 ➝ $245.00 | Buy ➝ Neutral | |
CHK Chesapeake Energy | Target Raised by | Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $81.46 -1.0% | $77.00 ➝ $83.00 | Equal Weight ➝ Equal Weight | |
CHRD Chord Energy | Target Lowered by | Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $130.59 +0.3% | $200.00 ➝ $185.00 | Overweight ➝ Overweight | |
CI The Cigna Group | Reiterated by | Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $348.10 +0.5% | $400.00 ➝ $400.00 | Overweight ➝ Overweight | |
CLX Clorox | Upgraded by | Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $165.32 +1.5% | $174.00 ➝ $187.00 | Hold ➝ Buy | |
CMS CMS Energy | Target Raised by | Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $71.05 +0.6% | $65.00 ➝ $76.00 | Outperform ➝ Outperform | |
CNC Centene | Reiterated by | Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $73.94 -1.8% | $90.00 ➝ $90.00 | Overweight ➝ Overweight | |
CNX CNX Resources | Downgraded by | Tudor, Pickering, Holt & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $32.66 +0.3% | | Hold ➝ Sell | |
CNX CNX Resources | Upgraded by | Tudor Pickering Subscribe to MarketBeat All Access for the recommendation accuracy rating | J. Roberts Subscribe to MarketBeat All Access for the recommendation accuracy rating | $32.66 +0.3% | | Strong Sell | |
COLB Columbia Banking System | Target Raised by | Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $25.28 -3.2% | $26.00 ➝ $28.00 | Equal Weight ➝ Equal Weight | |
CRGY Crescent Energy | Target Lowered by | Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $11.17 +2.0% | $21.00 ➝ $20.00 | Overweight ➝ Overweight | |
CRL Charles River Laboratories International | Downgraded by | Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating | P. Donnelly Subscribe to MarketBeat All Access for the recommendation accuracy rating | $194.09 -1.5% | $215.00 ➝ $175.00 | Neutral ➝ Sell | |
CSLR Complete Solaria | Reiterated by | Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $2.46 -12.8% | $6.00 ➝ $6.00 | Overweight ➝ Overweight | |
CTRA Coterra Energy | Target Lowered by | Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $24.15 +0.8% | $34.00 ➝ $32.00 | Overweight ➝ Overweight | |
CTRE CareTrust REIT | Upgraded by | Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating | J. Feldman Subscribe to MarketBeat All Access for the recommendation accuracy rating | $30.84 -0.1% | $28.00 ➝ $34.00 | Equal Weight ➝ Overweight | |
CVS CVS Health | Reiterated by | Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating | S. James Subscribe to MarketBeat All Access for the recommendation accuracy rating | $61.54 -2.1% | $62.00 ➝ $62.00 | Neutral ➝ Neutral | |
CWEN Clearway Energy | Initiated by | BNP Paribas Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $30.75 +0.2% | $36.00 | Outperform | |
CYBR CyberArk Software | Target Raised by | Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $279.70 -4.1% | $300.00 ➝ $325.00 | Outperform ➝ Outperform | |
DBRG DigitalBridge Group | Target Raised by | JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $13.77 -2.5% | $22.00 ➝ $23.00 | Overweight ➝ Overweight | |
DDOG Datadog | Upgraded by | DA Davidson Subscribe to MarketBeat All Access for the recommendation accuracy rating | G. Luria Subscribe to MarketBeat All Access for the recommendation accuracy rating | $113.98 -0.9% | $115.00 ➝ $140.00 | Neutral ➝ Buy | |
DHR Danaher | Initiated by | Stephens Subscribe to MarketBeat All Access for the recommendation accuracy rating | J. Johnson Subscribe to MarketBeat All Access for the recommendation accuracy rating | $274.54 -1.3% | $315.00 | Overweight | |
DHR Danaher | Target Raised by | Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating | V. Kumar Subscribe to MarketBeat All Access for the recommendation accuracy rating | $274.54 -1.3% | $275.00 ➝ $278.00 | Outperform ➝ Outperform | |
DIN Dine Brands Global | Upgraded by | Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating | N. Setyan Subscribe to MarketBeat All Access for the recommendation accuracy rating | $34.73 +11.2% | $34.00 ➝ $47.00 | Neutral ➝ Outperform | |
DIS Walt Disney | Reiterated by | Raymond James Subscribe to MarketBeat All Access for the recommendation accuracy rating | R. Prentiss Subscribe to MarketBeat All Access for the recommendation accuracy rating | $94.05 -2.2% | | Outperform ➝ Market Perform | |
DLR Digital Realty Trust | Target Raised by | JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $160.31 -0.9% | $175.00 ➝ $180.00 | Overweight ➝ Overweight | |
DOC Healthpeak Properties | Reiterated by | Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating | J. Feldman Subscribe to MarketBeat All Access for the recommendation accuracy rating | $22.66 -0.9% | $22.00 ➝ $23.00 | Equal Weight ➝ Equal Weight | |
DUK Duke Energy | Target Raised by | Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $116.22 +0.8% | $102.00 ➝ $118.00 | Overweight ➝ Overweight | |
DVN Devon Energy | Target Lowered by | Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $39.77 +1.7% | $55.00 ➝ $50.00 | Overweight ➝ Overweight | |
EAT Brinker International | Downgraded by | Argus Subscribe to MarketBeat All Access for the recommendation accuracy rating | W. Selesky Subscribe to MarketBeat All Access for the recommendation accuracy rating | $78.75 +2.9% | | Buy ➝ Hold | |
EEFT Euronet Worldwide | Initiated by | Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $98.79 -0.4% | $121.00 | Outperform | |
EFX Equifax | Initiated by | UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | K. Mcveigh Subscribe to MarketBeat All Access for the recommendation accuracy rating | $290.30 -1.2% | $360.00 | Buy | |
ELF e.l.f. Beauty | Reiterated by | DA Davidson Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $105.97 -2.8% | $223.00 ➝ $223.00 | Buy ➝ Buy | |
ELV Elevance Health | Reiterated by | Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $510.99 -1.7% | $600.00 ➝ $600.00 | Overweight ➝ Overweight | |
ELVN Enliven Therapeutics | Reiterated by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | R. Burns Subscribe to MarketBeat All Access for the recommendation accuracy rating | $26.00 +1.8% | $37.00 ➝ $37.00 | Buy ➝ Buy | |
ENOV Enovis | Target Lowered by | Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $41.47 -3.7% | $62.00 ➝ $58.00 | Outperform ➝ Outperform | |
EOG EOG Resources | Target Lowered by | Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $126.93 +3.3% | $140.00 ➝ $135.00 | Equal Weight ➝ Equal Weight | |
EPR EPR Properties | Reiterated by | Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $48.34 -1.4% | $45.00 ➝ $47.00 | Underweight ➝ Underweight | |
EPRT Essential Properties Realty Trust | Reiterated by | Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $33.51 -1.9% | $34.00 ➝ $37.00 | Overweight ➝ Overweight | |
EPSN Epsilon Energy | Initiated by | Roth Mkm Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $5.84 -0.3% | $7.00 | Buy | |
EPSN Epsilon Energy | Upgraded by | Roth Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating | J. White Subscribe to MarketBeat All Access for the recommendation accuracy rating | $5.84 -0.3% | | Strong-Buy | |
EQIX Equinix | Target Raised by | JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $883.00 -0.5% | $950.00 ➝ $975.00 | Overweight ➝ Overweight | |
ESTA Establishment Labs | Target Raised by | Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $40.56 -6.3% | $45.00 ➝ $50.00 | Neutral ➝ Neutral | |
EW Edwards Lifesciences | Target Lowered by | Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $65.09 -1.4% | $83.00 ➝ $77.00 | Buy ➝ Buy | |
EW Edwards Lifesciences | Target Lowered by | Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $65.09 -1.4% | $76.00 ➝ $70.00 | In-Line ➝ In-Line | |
EWBC East West Bancorp | Target Raised by | Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $80.04 -3.3% | $95.00 ➝ $97.00 | Overweight ➝ Overweight | |
EXAS Exact Sciences | Target Raised by | Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating | V. Kumar Subscribe to MarketBeat All Access for the recommendation accuracy rating | $68.04 -0.1% | $72.00 ➝ $80.00 | Outperform ➝ Outperform | |
F Ford Motor | Upgraded by | The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | M. Delaney Subscribe to MarketBeat All Access for the recommendation accuracy rating | $10.76 +1.9% | $12.00 ➝ $13.00 | Neutral ➝ Buy | |
We’re in a code red crisis and 99% of Americans are clueless (Ad) right now governments around the world are stockpiling this resource at the fastest rate in DECADES!
Discover what that resource is… (Spoiler: It's NOT what you might think.) And how YOU can prepare for the next 2024 BOOM here! |
FANG Diamondback Energy | Target Lowered by | Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $177.52 +3.0% | $230.00 ➝ $219.00 | Overweight ➝ Overweight | |
FBP First BanCorp. | Target Raised by | Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $20.10 -5.1% | $20.00 ➝ $22.00 | Equal Weight ➝ Equal Weight | |
FCPT Four Corners Property Trust | Reiterated by | Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating | J. Feldman Subscribe to MarketBeat All Access for the recommendation accuracy rating | $29.31
| $28.00 ➝ $32.00 | Overweight ➝ Overweight | |
FHB First Hawaiian | Target Lowered by | Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $22.54 -2.6% | $22.00 ➝ $20.00 | Underweight ➝ Underweight | |
FI Fiserv | Initiated by | Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $181.33 +0.9% | $170.00 ➝ $203.00 | Outperform | |
FIBK First Interstate BancSystem | Downgraded by | Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating | T. Braziler Subscribe to MarketBeat All Access for the recommendation accuracy rating | $29.54 -3.7% | $30.00 ➝ $28.00 | Equal Weight ➝ Underweight | |
FICO Fair Isaac | Initiated by | UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | K. Mcveigh Subscribe to MarketBeat All Access for the recommendation accuracy rating | $1,912.65 -1.6% | $2,100.00 | Neutral | |
FICO Fair Isaac | Target Raised by | Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating | J. Haas Subscribe to MarketBeat All Access for the recommendation accuracy rating | $1,912.65 -1.6% | $2,100.00 ➝ $2,200.00 | Overweight ➝ Overweight | |
FIS Fidelity National Information Services | Initiated by | Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $83.67 -0.1% | | Market Perform | |
FLNC Fluence Energy | Downgraded by | Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating | R. Levine Subscribe to MarketBeat All Access for the recommendation accuracy rating | $21.57 -5.0% | $32.00 ➝ $24.00 | Buy ➝ Neutral | |
FNV Franco-Nevada | Downgraded by | Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $125.07 +0.7% | $142.00 ➝ $139.00 | Buy ➝ Neutral | |
FOUR Shift4 Payments | Initiated by | Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $88.39 -0.2% | $109.00 | Outperform | |
FSLY Fastly | Downgraded by | Raymond James Subscribe to MarketBeat All Access for the recommendation accuracy rating | F. Louthan Subscribe to MarketBeat All Access for the recommendation accuracy rating | $7.19 -5.1% | | Strong-Buy ➝ Market Perform | |
GANX Gain Therapeutics | Reiterated by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | R. Selvaraju Subscribe to MarketBeat All Access for the recommendation accuracy rating | $1.64 -7.9% | $8.00 ➝ $8.00 | Buy ➝ Buy | |
GD General Dynamics | Downgraded by | Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating | M. Akers Subscribe to MarketBeat All Access for the recommendation accuracy rating | $305.32 +1.0% | $334.00 ➝ $317.00 | Overweight ➝ Equal Weight | |
GEHC GE HealthCare Technologies | Target Raised by | Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $91.67 -2.3% | $98.00 ➝ $102.00 | Outperform ➝ Outperform | |
GLPI Gaming and Leisure Properties | Reiterated by | Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $51.14 -0.6% | $51.00 ➝ $52.00 | Equal Weight ➝ Equal Weight | |
GM General Motors | Target Raised by | The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $44.87 +0.1% | $53.00 ➝ $61.00 | Buy ➝ Buy | |
GNTX Gentex | Target Lowered by | The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $29.47 -0.7% | $33.00 ➝ $31.00 | Neutral ➝ Neutral | |
GOOG Alphabet | Initiated by | Pivotal Research Subscribe to MarketBeat All Access for the recommendation accuracy rating | J. Wlodarczak Subscribe to MarketBeat All Access for the recommendation accuracy rating | $168.42 +0.7% | $215.00 | Buy | |
GOOGL Alphabet | Upgraded by | Pivotal Research Subscribe to MarketBeat All Access for the recommendation accuracy rating | J. Wlodarczak Subscribe to MarketBeat All Access for the recommendation accuracy rating | $166.99 +0.7% | | Strong-Buy | |
GPN Global Payments | Initiated by | Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $100.43 -2.0% | | Market Perform | |
GRTS Gritstone bio | Reiterated by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | S. Lee Subscribe to MarketBeat All Access for the recommendation accuracy rating | $0.22 -62.1% | $4.00 ➝ $0.50 | Buy ➝ Neutral | |
GRTS Gritstone bio | Downgraded by | JMP Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating | R. Buchanan Subscribe to MarketBeat All Access for the recommendation accuracy rating | $0.22 -62.1% | | Outperform ➝ Market Perform | |
HAS Hasbro | Target Raised by | Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $72.89 +0.8% | $75.00 ➝ $83.00 | Buy ➝ Buy | |
HCA HCA Healthcare | Reiterated by | Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $405.45 -0.2% | $392.00 ➝ $392.00 | Overweight ➝ Overweight | |
HIW Highwoods Properties | Downgraded by | Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $33.28 -0.7% | $31.00 ➝ $35.00 | Buy ➝ Hold | |
HOLX Hologic | Target Raised by | Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $80.56 -1.1% | $78.00 ➝ $82.00 | In-Line ➝ In-Line | |
HOLX Hologic | Downgraded by | Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating | P. Donnelly Subscribe to MarketBeat All Access for the recommendation accuracy rating | $80.56 -1.1% | $95.00 ➝ $85.00 | Buy ➝ Neutral | |
HPQ HP | Downgraded by | Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating | A. Merchant Subscribe to MarketBeat All Access for the recommendation accuracy rating | $34.75 -3.1% | $37.00 ➝ $37.00 | Buy ➝ Neutral | |
HR Healthcare Realty Trust | Reiterated by | Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating | J. Feldman Subscribe to MarketBeat All Access for the recommendation accuracy rating | $17.90 -1.4% | $16.00 ➝ $17.00 | Underweight ➝ Underweight | |
HUM Humana | Reiterated by | Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $279.42 -11.8% | $395.00 ➝ $395.00 | Neutral ➝ Neutral | |
HYLN Hyliion | Upgraded by | Northland Capmk Subscribe to MarketBeat All Access for the recommendation accuracy rating | E. Jackson Subscribe to MarketBeat All Access for the recommendation accuracy rating | $2.27 -8.5% | | Hold | |
IART Integra LifeSciences | Target Lowered by | Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating | J. Wuensch Subscribe to MarketBeat All Access for the recommendation accuracy rating | $17.50 -3.7% | $20.00 ➝ $16.00 | Sell ➝ Sell | |
IGMS IGM Biosciences | Target Lowered by | Guggenheim Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $14.50 -12.3% | $25.00 ➝ $20.00 | Buy ➝ Buy | |
IGMS IGM Biosciences | Downgraded by | Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating | A. Goonewardene Subscribe to MarketBeat All Access for the recommendation accuracy rating | $14.50 -12.3% | $24.00 ➝ $12.00 | Buy ➝ Hold | |
IGMS IGM Biosciences | Downgraded by | JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $14.50 -12.3% | $12.00 ➝ $9.00 | Neutral ➝ Underweight | |
IGMS IGM Biosciences | Target Lowered by | Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $14.50 -12.3% | $25.00 ➝ $22.00 | Outperform ➝ Outperform | |
IGMS IGM Biosciences | Target Lowered by | Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $14.50 -12.3% | $20.00 ➝ $17.00 | Outperform ➝ Outperform | |
IMXI International Money Express | Initiated by | Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $17.57 -5.0% | | Market Perform | |
INCY Incyte | Initiated by | Wolfe Research Subscribe to MarketBeat All Access for the recommendation accuracy rating | A. Chen Subscribe to MarketBeat All Access for the recommendation accuracy rating | $68.06 +3.0% | $84.00 | Outperform | |
IPG Interpublic Group of Companies | Downgraded by | JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $31.22 -1.3% | $36.00 ➝ $33.00 | Overweight ➝ Neutral | |
ISRG Intuitive Surgical | Target Raised by | Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $484.76 -1.3% | $410.00 ➝ $475.00 | In-Line ➝ In-Line | |
ITGR Integer | Target Raised by | Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $127.19 -2.2% | $124.00 ➝ $130.00 | Neutral ➝ Neutral | |
ITGR Integer | Target Raised by | Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating | R. Newitter Subscribe to MarketBeat All Access for the recommendation accuracy rating | $127.19 -2.2% | $137.00 ➝ $145.00 | Buy ➝ Buy | |
ITGR Integer | Target Raised by | Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $127.19 -2.2% | $135.00 ➝ $145.00 | Buy ➝ Buy | |
JAMF Jamf | Reiterated by | JMP Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $16.95 -2.3% | $30.00 | Market Outperform | |
JKHY Jack Henry & Associates | Initiated by | Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $179.70 +1.8% | $181.00 ➝ $206.00 | Outperform | |
KRNT Kornit Digital | Target Raised by | Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $25.28 -2.1% | $21.00 ➝ $26.00 | Equal Weight ➝ Equal Weight | |
KTOS Kratos Defense & Security Solutions | Reiterated by | JMP Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating | T. Walsh Subscribe to MarketBeat All Access for the recommendation accuracy rating | $24.82 +6.5% | $27.00 ➝ $27.00 | Market Outperform ➝ Market Outperform | |
Next Week Elon Could Trigger a Boom in this Sub-$3 Stock (Ad) Next week, you’ll have a chance to get in on the ground floor of what could be Elon’s next big thing.
You see, he’s set to reveal his new AI product that I believe will shock the world… Click here to see the details and save your seat. |
LCII LCI Industries | Initiated by | Raymond James Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $121.19 +0.5% | | Market Perform | |
LDOS Leidos | Target Raised by | Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $165.01 +1.2% | $172.00 ➝ $183.00 | Overweight ➝ Overweight | |
LEA Lear | Target Lowered by | The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $108.10 -1.0% | $144.00 ➝ $135.00 | Buy ➝ Buy | |
LH Laboratory Co. of America | Initiated by | Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating | D. Westenberg Subscribe to MarketBeat All Access for the recommendation accuracy rating | $219.20 -1.9% | $235.00 | Neutral | |
LTC LTC Properties | Reiterated by | Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $36.57 -0.3% | $36.00 ➝ $37.00 | Equal Weight ➝ Equal Weight | |
LULU Lululemon Athletica | Target Lowered by | Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $266.45 -1.8% | $326.00 ➝ $314.00 | Overweight ➝ Overweight | |
LVS Las Vegas Sands | Target Raised by | Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $51.83 +3.0% | $53.00 ➝ $60.00 | Overweight ➝ Overweight | |
MA Mastercard | Initiated by | Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $496.19 +0.5% | $591.00 | Outperform | |
MAT Mattel | Target Raised by | Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $19.13 +0.4% | $18.25 ➝ $20.00 | Hold ➝ Hold | |
MBLY Mobileye Global | Target Lowered by | The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $13.44 -1.9% | $24.00 ➝ $20.00 | Buy ➝ Buy | |
MDT Medtronic | Target Raised by | Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $89.99 0.0% | $85.00 ➝ $92.00 | Neutral ➝ Neutral | |
MDT Medtronic | Target Raised by | Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $89.99 0.0% | $100.00 ➝ $104.00 | Outperform ➝ Outperform | |
META Meta Platforms | Initiated by | Pivotal Research Subscribe to MarketBeat All Access for the recommendation accuracy rating | J. Wlodarczak Subscribe to MarketBeat All Access for the recommendation accuracy rating | $576.47 +0.7% | $780.00 | Buy | |
MGA Magna International | Target Lowered by | The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $40.96 -0.2% | $44.00 ➝ $41.00 | Neutral ➝ Neutral | |
MGM MGM Resorts International | Target Lowered by | Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $38.62 -1.2% | $57.00 ➝ $52.00 | Buy ➝ Buy | |
MGY Magnolia Oil & Gas | Downgraded by | Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating | H. Chang Subscribe to MarketBeat All Access for the recommendation accuracy rating | $24.86 +1.8% | $26.00 ➝ $22.00 | Equal Weight ➝ Underweight | |
ML MoneyLion | Initiated by | Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $37.41 -10.0% | | Market Perform | |
MLAB Mesa Laboratories | Target Raised by | Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $130.39 +0.4% | $120.00 ➝ $160.00 | Outperform ➝ Outperform | |
MMC Marsh & McLennan Companies | Target Raised by | Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $222.79 -0.1% | $235.00 ➝ $248.00 | Neutral ➝ Neutral | |
MNDY monday.com | Target Raised by | Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating | R. Macwilliams Subscribe to MarketBeat All Access for the recommendation accuracy rating | $269.14 -3.1% | $300.00 ➝ $325.00 | Overweight ➝ Overweight | |
MOH Molina Healthcare | Reiterated by | Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $341.91 -0.8% | $406.00 ➝ $406.00 | Overweight ➝ Overweight | |
MP MP Materials | Target Raised by | DA Davidson Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $17.54 -0.6% | $20.00 ➝ $23.00 | Buy ➝ Buy | |
MREO Mereo BioPharma Group | Reiterated by | Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $4.17 +1.5% | $7.00 ➝ $7.00 | Overweight ➝ Overweight | |
MRO Marathon Oil | Target Lowered by | Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $27.64 +3.8% | $29.00 ➝ $27.00 | Equal Weight ➝ Equal Weight | |
MRUS Merus | Target Raised by | Guggenheim Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $50.10 +0.3% | $93.00 ➝ $111.00 | Buy ➝ Buy | |
MTD Mettler-Toledo International | Target Raised by | Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $1,477.12 -1.5% | $1,375.00 ➝ $1,450.00 | In-Line ➝ In-Line | |
MTDR Matador Resources | Target Lowered by | Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $50.49 +2.2% | $89.00 ➝ $87.00 | Overweight ➝ Overweight | |
MU Micron Technology | Reiterated by | Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $100.31 -3.3% | $150.00 ➝ $150.00 | Overweight ➝ Overweight | |
MXL MaxLinear | Downgraded by | Susquehanna Subscribe to MarketBeat All Access for the recommendation accuracy rating | C. Rolland Subscribe to MarketBeat All Access for the recommendation accuracy rating | $12.73 -12.1% | $26.00 ➝ $15.00 | Positive ➝ Neutral | |
NEE NextEra Energy | Target Raised by | Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $85.29 +0.9% | $76.00 ➝ $80.00 | Equal Weight ➝ Equal Weight | |
NEOV NeoVolta | Target Raised by | Maxim Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $2.94 -4.9% | $4.25 ➝ $4.75 | Buy ➝ Buy | |
NEP NextEra Energy Partners | Initiated by | BNP Paribas Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $26.98 -2.3% | $15.00 | Underperform | |
NFE New Fortress Energy | Reiterated by | Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $9.68 +6.5% | $21.00 ➝ $7.60 | Hold ➝ Sell | |
NFLX Netflix | Target Raised by | KeyCorp Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $706.13 -0.4% | $735.00 ➝ $760.00 | Overweight ➝ Overweight | |
NHI National Health Investors | Downgraded by | Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating | J. Feldman Subscribe to MarketBeat All Access for the recommendation accuracy rating | $83.08 -1.2% | $81.00 ➝ $86.00 | Overweight ➝ Equal Weight | |
NMRA Neumora Therapeutics | Initiated by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | D. Tsao Subscribe to MarketBeat All Access for the recommendation accuracy rating | $13.50 +2.2% | $30.00 | Buy | |
NNN NNN REIT | Reiterated by | Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $48.63 +0.3% | $47.00 ➝ $50.00 | Equal Weight ➝ Equal Weight | |
NVCR NovoCure | Target Lowered by | Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $14.89 -4.7% | $21.00 ➝ $18.00 | In-Line ➝ In-Line | |
NVRO Nevro | Target Lowered by | Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating | J. Wuensch Subscribe to MarketBeat All Access for the recommendation accuracy rating | $5.23 -6.4% | $6.89 ➝ $6.00 | Neutral ➝ Neutral | |
NYAX Nayax | Initiated by | Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $25.69 +1.9% | | Market Perform | |
O Realty Income | Reiterated by | Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $62.99 -0.7% | $62.00 ➝ $65.00 | Equal Weight ➝ Equal Weight | |
OHI Omega Healthcare Investors | Reiterated by | Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating | J. Feldman Subscribe to MarketBeat All Access for the recommendation accuracy rating | $40.39 -0.8% | $40.00 ➝ $43.00 | Overweight ➝ Overweight | |
OMC Omnicom Group | Target Raised by | JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $102.69 -0.7% | $106.00 ➝ $118.00 | Overweight ➝ Overweight | |
ONTO Onto Innovation | Target Raised by | Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $200.34 -3.5% | $260.00 ➝ $275.00 | Outperform ➝ Outperform | |
OVV Ovintiv | Target Lowered by | Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $40.34 +5.3% | $51.00 ➝ $42.00 | Equal Weight ➝ Equal Weight | |
PAGS PagSeguro Digital | Downgraded by | Itau BBA Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $8.48 -1.5% | $12.00 | Outperform ➝ Market Perform | |
PATK Patrick Industries | Initiated by | Raymond James Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $144.32 +1.4% | $160.00 | Outperform | |
PEP PepsiCo | Target Raised by | JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $171.38 +0.8% | $182.00 ➝ $185.00 | Neutral ➝ Neutral | |
PFSI PennyMac Financial Services | Target Raised by | Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $112.14 -1.6% | $112.00 ➝ $125.00 | Overweight ➝ Overweight | |
PGNY Progyny | Reiterated by | Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $16.18 -3.5% | $25.00 ➝ $25.00 | Overweight ➝ Overweight | |
Seven “Forever Stocks” could enrich shareholders for decades (Ad) A few weeks ago, I asked my research team to investigate the top 10 best-performing stocks of the last 30 years.
And the results will shock you! Seven Stocks to buy and Hold Forever |
PGY Pagaya Technologies | Initiated by | Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $9.94 -6.0% | $12.00 | Outperform | |
PLXS Plexus | Target Raised by | Benchmark Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $134.72 -1.5% | $145.00 ➝ $150.00 | Buy ➝ Buy | |
PM Philip Morris International | Target Raised by | Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $120.58 -0.7% | $118.00 ➝ $135.00 | Buy ➝ Buy | |
PNFP Pinnacle Financial Partners | Downgraded by | Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating | T. Braziler Subscribe to MarketBeat All Access for the recommendation accuracy rating | $93.19 -4.9% | $100.00 ➝ $100.00 | Overweight ➝ Equal Weight | |
PODD Insulet | Target Raised by | Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $234.56 +0.8% | $250.00 ➝ $275.00 | Buy ➝ Buy | |
PR Permian Resources | Target Lowered by | Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $13.81 +1.5% | $22.00 ➝ $21.00 | Overweight ➝ Overweight | |
PRG PROG | Target Raised by | Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $47.29 -2.5% | $50.00 ➝ $58.00 | Buy ➝ Buy | |
PRMW Primo Water | Reiterated by | Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $24.94 -1.2% | $30.00 ➝ $30.00 | Outperform ➝ Outperform | |
PRTA Prothena | Target Lowered by | Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $16.65 -0.5% | $33.00 ➝ $31.00 | Neutral ➝ Neutral | |
PRTA Prothena | Reiterated by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $16.65 -0.5% | $84.00 ➝ $84.00 | Buy ➝ Buy | |
PTON Peloton Interactive | Reiterated by | BMO Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $4.34 -7.3% | $6.50 ➝ $6.50 | Market Perform ➝ Market Perform | |
PYPL PayPal | Initiated by | Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $77.47 -0.7% | | Market Perform | |
RARE Ultragenyx Pharmaceutical | Reiterated by | Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $56.51 +1.7% | $116.00 ➝ $116.00 | Overweight ➝ Overweight | |
RLYB Rallybio | Reiterated by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $1.12 -4.3% | $6.00 ➝ $6.00 | Buy ➝ Buy | |
RMD ResMed | Reiterated by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | M. Matson Subscribe to MarketBeat All Access for the recommendation accuracy rating | $238.75 -2.2% | | Hold | |
RMD ResMed | Target Raised by | Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $238.75 -2.2% | $206.00 ➝ $224.00 | Sector Perform ➝ Sector Perform | |
ROKU Roku | Upgraded by | Moffett Nathanson Subscribe to MarketBeat All Access for the recommendation accuracy rating | M. Nathanson Subscribe to MarketBeat All Access for the recommendation accuracy rating | $74.34 -0.4% | $80.00 | Sell ➝ Neutral | |
RRC Range Resources | Upgraded by | Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating | R. Read Subscribe to MarketBeat All Access for the recommendation accuracy rating | $30.88 +0.4% | $35.00 ➝ $39.00 | Equal Weight ➝ Overweight | |
SATS EchoStar | Downgraded by | Raymond James Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $24.09 -2.9% | | Strong-Buy ➝ Market Perform | |
SBRA Sabra Health Care REIT | Upgraded by | Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating | J. Feldman Subscribe to MarketBeat All Access for the recommendation accuracy rating | $18.58 -0.2% | $16.00 ➝ $20.00 | Equal Weight ➝ Overweight | |
SHOP Shopify | Target Raised by | Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $78.47 -2.1% | $65.00 ➝ $70.00 | Equal Weight ➝ Equal Weight | |
SLB Schlumberger | Target Lowered by | JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $43.14 +2.8% | $64.00 ➝ $60.00 | Overweight ➝ Overweight | |
SLNO Soleno Therapeutics | Target Raised by | Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $49.63 -1.7% | $59.00 ➝ $74.00 | Buy ➝ Buy | |
SM SM Energy | Target Lowered by | Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $41.33 +3.4% | $48.00 ➝ $43.00 | Equal Weight ➝ Equal Weight | |
SN SharkNinja | Initiated by | Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $107.95 -0.7% | $120.00 | Outperform | |
SNOW Snowflake | Initiated by | Argus Subscribe to MarketBeat All Access for the recommendation accuracy rating | J. Bonner Subscribe to MarketBeat All Access for the recommendation accuracy rating | $110.23 -4.0% | | Hold | |
SNV Synovus Financial | Downgraded by | Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating | T. Braziler Subscribe to MarketBeat All Access for the recommendation accuracy rating | $42.49 -4.5% | $48.00 ➝ $46.00 | Overweight ➝ Equal Weight | |
SQ Block | Initiated by | Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $65.95 -1.8% | | Market Perform | |
SRE Sempra | Target Raised by | Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $83.93 +0.4% | $87.00 ➝ $89.00 | Overweight ➝ Overweight | |
ST Sensata Technologies | Target Lowered by | The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $35.15 -2.0% | $41.00 ➝ $39.00 | Neutral ➝ Neutral | |
STEP StepStone Group | Target Raised by | JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $58.08 +2.2% | $56.00 ➝ $61.00 | Overweight ➝ Overweight | |
STLD Steel Dynamics | Upgraded by | Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $129.23 +2.5% | $140.00 ➝ $155.00 | Neutral ➝ Buy | |
STTK Shattuck Labs | Downgraded by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | J. Pantginis Subscribe to MarketBeat All Access for the recommendation accuracy rating | $1.92 -45.0% | | Buy ➝ Neutral | |
SVRA Savara | Reiterated by | JMP Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $3.99 -5.9% | $9.00 ➝ $9.00 | Market Outperform ➝ Market Outperform | |
SVRA Savara | Reiterated by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $3.99 -5.9% | $10.00 ➝ $10.00 | Buy ➝ Buy | |
SYK Stryker | Target Raised by | Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $357.36 -1.1% | $365.00 ➝ $380.00 | Outperform ➝ Outperform | |
TEAM Atlassian | Upgraded by | Raymond James Subscribe to MarketBeat All Access for the recommendation accuracy rating | A. Tindle Subscribe to MarketBeat All Access for the recommendation accuracy rating | $161.42 +1.6% | $200.00 | Market Perform ➝ Outperform | |
TEL TE Connectivity | Target Lowered by | The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $147.46 -2.3% | $189.00 ➝ $179.00 | Buy ➝ Buy | |
TFII TFI International | Target Lowered by | CIBC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $135.27 -1.2% | $179.00 ➝ $174.00 | Outperform | |
TFII TFI International | Reiterated by | Stephens Subscribe to MarketBeat All Access for the recommendation accuracy rating | D. Imbro Subscribe to MarketBeat All Access for the recommendation accuracy rating | $135.27 -1.2% | $176.00 ➝ $149.00 | Overweight ➝ Equal Weight | |
THC Tenet Healthcare | Reiterated by | Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $162.75 -2.1% | $168.00 ➝ $168.00 | Overweight ➝ Overweight | |
THO THOR Industries | Reiterated by | Benchmark Subscribe to MarketBeat All Access for the recommendation accuracy rating | M. Albanese Subscribe to MarketBeat All Access for the recommendation accuracy rating | $110.25 +0.3% | | Hold | |
TMO Thermo Fisher Scientific | Target Raised by | Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $612.92 -0.9% | $605.00 ➝ $630.00 | Outperform ➝ Outperform | |
TMO Thermo Fisher Scientific | Initiated by | Stephens Subscribe to MarketBeat All Access for the recommendation accuracy rating | J. Johnson Subscribe to MarketBeat All Access for the recommendation accuracy rating | $612.92 -0.9% | $680.00 | Overweight | |
TRU TransUnion | Initiated by | UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | K. Mcveigh Subscribe to MarketBeat All Access for the recommendation accuracy rating | $103.45 -1.2% | $110.00 | Neutral | |
TTD Trade Desk | Target Raised by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $108.72 -0.8% | $115.00 ➝ $125.00 | Buy ➝ Buy | |
TTEC TTEC | Upgraded by | Guggenheim Subscribe to MarketBeat All Access for the recommendation accuracy rating | J. Lee Subscribe to MarketBeat All Access for the recommendation accuracy rating | $5.98 +1.9% | | Sell ➝ Neutral | |
TVTX Travere Therapeutics | Target Raised by | Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $13.99
| $14.00 ➝ $18.00 | Overweight ➝ Overweight | |
TWST Twist Bioscience | Target Raised by | Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $43.40 -3.9% | $52.00 ➝ $56.00 | Outperform ➝ Outperform | |
TXRH Texas Roadhouse | Target Raised by | Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $177.22 +0.4% | $192.00 ➝ $201.00 | Buy ➝ Buy | |
UHS Universal Health Services | Reiterated by | Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating | S. James Subscribe to MarketBeat All Access for the recommendation accuracy rating | $224.66 -1.9% | $219.00 ➝ $219.00 | Neutral ➝ Neutral | |
UNH UnitedHealth Group | Reiterated by | Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $583.33 -0.2% | $591.00 ➝ $591.00 | Overweight ➝ Overweight | |
UPBD Upbound Group | Target Lowered by | Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $29.78 -6.9% | $37.00 ➝ $35.00 | Hold ➝ Hold | |
V Visa | Initiated by | Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $277.62 +1.0% | $289.00 ➝ $318.00 | Outperform | |
VC Visteon | Target Lowered by | The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $93.58 -1.7% | $130.00 ➝ $117.00 | Buy ➝ Buy | |
VEEV Veeva Systems | Target Raised by | Guggenheim Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $207.65 -1.1% | $233.00 ➝ $249.00 | Buy ➝ Buy | |
VERA Vera Therapeutics | Reiterated by | Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $42.83 -3.1% | $107.00 ➝ $107.00 | Overweight ➝ Overweight | |
VICI VICI Properties | Reiterated by | Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $32.77 -1.6% | $33.00 ➝ $36.00 | Overweight ➝ Overweight | |
VRNA Verona Pharma | Reiterated by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $28.99 +0.8% | $36.00 ➝ $36.00 | Buy ➝ Buy | |
VRTX Vertex Pharmaceuticals | Target Raised by | Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $469.76 +1.0% | $462.00 ➝ $474.00 | Equal Weight ➝ Equal Weight | |
VTLE Vital Energy | Target Lowered by | Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $27.36 +1.7% | $41.00 ➝ $29.00 | Equal Weight ➝ Equal Weight | |
VTR Ventas | Upgraded by | Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating | J. Feldman Subscribe to MarketBeat All Access for the recommendation accuracy rating | $63.89 +0.3% | $61.00 ➝ $71.00 | Equal Weight ➝ Overweight | |
VZ Verizon Communications | Target Raised by | Tigress Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $45.21 +0.7% | $52.00 ➝ $55.00 | Buy ➝ Buy | |
WAL Western Alliance Bancorporation | Target Raised by | Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $83.76 -3.2% | $85.00 ➝ $92.00 | Equal Weight ➝ Equal Weight | |
WAT Waters | Target Raised by | Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $358.33 -0.4% | $335.00 ➝ $355.00 | In-Line ➝ In-Line | |
WELL Welltower | Reiterated by | Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $127.65 -0.3% | $134.00 ➝ $135.00 | Overweight ➝ Equal Weight | |
WIX Wix.com | Target Lowered by | Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $157.49 -5.8% | $186.00 ➝ $184.00 | Overweight ➝ Overweight | |
WPC W. P. Carey | Reiterated by | Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $61.32 -1.6% | $62.00 ➝ $63.00 | Equal Weight ➝ Equal Weight | |
XENE Xenon Pharmaceuticals | Initiated by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | D. Tsao Subscribe to MarketBeat All Access for the recommendation accuracy rating | $40.38 +2.6% | $53.00 | Buy | |
ZBH Zimmer Biomet | Target Lowered by | Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $107.34 -0.6% | $113.00 ➝ $110.00 | In-Line ➝ In-Line | |
ZETA Zeta Global | Target Raised by | Roth Mkm Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $29.67 -0.5% | $33.00 ➝ $44.00 | Buy ➝ Buy | |
ZVRA Zevra Therapeutics | Reiterated by | Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $6.85 -1.3% | | Overweight | |